MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-05-2026
National Research Corporation Total Shareholders Equity 2011-2026 | NRC
Annual Total Shareholders Equity National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 M | 31.3 M | 49 M | 72 M | 85.3 M | 64.3 M | 32.9 M | 19.1 M | 90 M | 82.8 M | 74.2 M | 87.7 M | 71.8 M | 56.7 M | 55.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90 M | 14 M | 59.1 M |
Quarterly Total Shareholders Equity National Research Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 21.3 M | 29.7 M | 31.3 M | 34.6 M | 40.2 M | 36.9 M | 49 M | 57.9 M | 77.8 M | 74.7 M | 72 M | 67.8 M | 68.6 M | 81.5 M | 85.3 M | 83.1 M | 76.4 M | 73.2 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M | 32.9 M | 32.9 M | 32.9 M | 32.9 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 90 M | 90 M | 90 M | 90 M | 82.8 M | 82.8 M | 82.8 M | 82.8 M | 74.2 M | 74.2 M | 74.2 M | 74.2 M | 87.7 M | 87.7 M | 87.7 M | 87.7 M | 71.8 M | 71.8 M | 71.8 M | 71.8 M | 56.7 M | 56.7 M | 56.7 M | 56.7 M | 55.6 M | 55.6 M | 55.6 M | 55.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 90 M | 14.3 M | 61.3 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 16.65 | -12.64 % | $ 179 M |  China |
|
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
456 M | $ 24.69 | - | $ 686 M |  USA |
 |
Agilent Technologies
A
|
5.39 B | $ 114.87 | - | $ 34.9 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 126.92 | - | $ 20.2 B | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 83.55 | - | $ 5.64 B | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11.9 B | $ 27.12 | - | $ 20 B |  Niderland |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 1.63 | - | $ 2.17 M | USA |
 |
Personalis
PSNL
|
203 M | $ 5.5 | - | $ 326 M | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 21.91 | - | $ 1.17 B | USA |
 |
Senseonics Holdings
SENS
|
61 M | $ 7.18 | - | $ 300 M | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 15.3 | - | $ 463 M | USA |
 |
Trinity Biotech plc
TRIB
|
-2.22 M | $ 0.61 | - | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 59.15 | - | $ 3.54 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 166.79 | 0.05 % | $ 8.27 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 83.09 | - | $ 10.4 B | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.93 | - | $ 8.54 M | USA |
 |
Exagen
XGN
|
17.4 M | $ 2.73 | -0.36 % | $ 58.9 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Medpace Holdings
MEDP
|
459 M | $ 409.65 | - | $ 11.8 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.18 | -0.46 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 102.49 | - | $ 8.45 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 259.57 | - | $ 21.6 B | USA |
 |
NeoGenomics
NEO
|
837 M | $ 9.02 | - | $ 1.16 B | USA |
 |
Celcuity
CELC
|
101 M | $ 120.07 | - | $ 5.61 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.34 | - | $ 2.03 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.84 | - | $ 448 M | USA |
 |
Natera
NTRA
|
706 M | $ 200.17 | - | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 195.05 | - | $ 21.7 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | USA |